| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |